AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24400883 — intervention group
Group type: EXPERIMENTAL
Intervention: Formative assessment with summative components (Year 2)
Number of subjects: 259
Study 24400883 — intervention group
Group type: COMPARATOR
Intervention: Voluntary formative assessment (Year 1)
Number of subjects: 259
Study 22991777 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based intervention
Number of subjects: 28
Study 22991777 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 19778669 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 0
Study 19778669 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 0
Study 17165035 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-drainage (without closed suction drainage)
Number of subjects: 100
Study 17165035 — intervention group
Group type: COMPARATOR
Intervention: Closed suction drainage (CSD)
Number of subjects: 100
Study 15147225 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual student approaches (brief intervention based on motivational interviewing and written activities)
Number of subjects: 0
Study 15147225 — intervention group
Group type: EXPERIMENTAL
Intervention: Approaches to assist parents (letter of support for parents of students who smoke)
Number of subjects: 0
Study 15147225 — intervention group
Group type: EXPERIMENTAL
Intervention: School newsletter items
Number of subjects: 0
Study 11429516 — intervention group
Group type: EXPERIMENTAL
Intervention: New partially hydrolyzed formula
Number of subjects: 16
Study 11429516 — intervention group
Group type: COMPARATOR
Intervention: Conventional formula
Number of subjects: 16
Study 9428499 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial radiation (CRT) with intrathecal methotrexate (IT‐MTX)
Number of subjects: 110
Study 9428499 — intervention group
Group type: COMPARATOR
Intervention: Intermediate dose systemic methotrexate (IV‐MTX) with IT‐MTX
Number of subjects: 110
Study 7586244 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterozygous for factor V Leiden
Number of subjects: 77
Study 7586244 — intervention group
Group type: COMPARATOR
Intervention: Genetically unaffected subjects
Number of subjects: 77
Study 2568791 — intervention group
Group type: EXPERIMENTAL
Intervention: Iotrolan 300
Number of subjects: 0
Study 2568791 — intervention group
Group type: COMPARATOR
Intervention: Iohexol 300
Number of subjects: 0
Study 710 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromazepam
Number of subjects: 40
Study 710 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromazepam + Alcohol
Number of subjects: 40
Study 710 — intervention group
Group type: COMPARATOR
Intervention: Alcohol
Number of subjects: 40
Study 710 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine
Number of subjects: 40
Study 710 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulpiride
Number of subjects: 40
Study 710 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioridazine
Number of subjects: 40
Study 710 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 28984486 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii exergames
Number of subjects: 102
Study 28984486 — intervention group
Group type: COMPARATOR
Intervention: Traditional exercise
Number of subjects: 102
Study 27610616 — intervention group
Group type: COMPARATOR
Intervention: G‐CSF
Number of subjects: 60
Study 27610616 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 60
Study 24908099 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid intervention
Number of subjects: 0
Study 22721908 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid food
Number of subjects: 53
Study 22721908 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-solid food
Number of subjects: 53
Study 20545710 — intervention group
Group type: EXPERIMENTAL
Intervention: Blackcurrant seed oil (BCSO)
Number of subjects: 313
Study 20545710 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (placebo)
Number of subjects: 313
Study 18520310 — intervention group
Group type: EXPERIMENTAL
Intervention: Copayment policy for prescription drugs
Number of subjects: 0
Study 16033298 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose rosiglitazone/metformin 8 mg/2g per day
Number of subjects: 0
Study 16033298 — intervention group
Group type: COMPARATOR
Intervention: Metformin 3 g/day
Number of subjects: 0
Study 16033298 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone plus metformin
Number of subjects: 0
Study 11545760 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day
Number of subjects: 10101
Study 11545760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10101
Study 9559480 — intervention group
Group type: EXPERIMENTAL
Intervention: Nidek handheld automated keratometer
Number of subjects: 45
Study 9559480 — intervention group
Group type: COMPARATOR
Intervention: Zeiss keratometer
Number of subjects: 45
Study 7942525 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy
Number of subjects: 2611
Study 3224785 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 200
Study 3224785 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic treatment
Number of subjects: 200
Study 2239665 — intervention group
Group type: EXPERIMENTAL
Intervention: Ioxaglate
Number of subjects: 50
Study 2239665 — intervention group
Group type: COMPARATOR
Intervention: Iopamidol
Number of subjects: 50
Study 30945949 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention and nutritional education (n = 73)
Number of subjects: 150
Study 30945949 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 67)
Number of subjects: 150
Study 27686616 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiology Taping (KT)
Number of subjects: 24
Study 27686616 — intervention group
Group type: EXPERIMENTAL
Intervention: Athletic Taping (AT)
Number of subjects: 24
Study 27686616 — intervention group
Group type: COMPARATOR
Intervention: No Taping
Number of subjects: 24
Study 27686616 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiology Taping (KT) and Athletic Taping (AT)
Number of subjects: 24
Study 25501720 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 hour preoperative clear fluid fasting
Number of subjects: 131
Study 25501720 — intervention group
Group type: COMPARATOR
Intervention: 2 hours preoperative clear fluid fasting
Number of subjects: 131
Study 23273822 — intervention group
Group type: EXPERIMENTAL
Intervention: sorafenib (n=16) and sunitinib (n=3)
Number of subjects: 19
Study 23273822 — intervention group
Group type: EXPERIMENTAL
Intervention: DCE‐US
Number of subjects: 19
Study 21111683 — intervention group
Group type: EXPERIMENTAL
Intervention: Nociceptive flexion reflex (NFR) threshold measurement
Number of subjects: 0
Study 21111683 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibromyalgia Impact Questionnaire (FIQ)-total
Number of subjects: 0
Study 21111683 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibromyalgia Impact Questionnaire (FIQ)-pain
Number of subjects: 0
Study 20027345 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaferon (pediatric formulation)
Number of subjects: 0
Study 17216271 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-bundle ACL reconstruction
Number of subjects: 65
Study 17216271 — intervention group
Group type: COMPARATOR
Intervention: Single-bundle ACL reconstruction
Number of subjects: 65
Study 17216271 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 65
Study 14709951 — intervention group
Group type: EXPERIMENTAL
Intervention: St. John's wort extract (255 to 285 mg, 900 microg hypericin content)
Number of subjects: 0
Study 14709951 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (25 mg)
Number of subjects: 0
Study 14709951 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11471516 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0
Study 11471516 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamfetamine (dexamphetamine)
Number of subjects: 0
Study 11471516 — intervention group
Group type: COMPARATOR
Intervention: Non-drug measures
Number of subjects: 0
Study 9568701 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril treatment for 12 weeks
Number of subjects: 93
Study 9568701 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 12 weeks
Number of subjects: 93
Study 7852606 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonaversive training
Number of subjects: 0
Study 7852606 — intervention group
Group type: COMPARATOR
Intervention: Traditional (positive) behavior management training
Number of subjects: 0
Study 3399521 — intervention group
Group type: EXPERIMENTAL
Intervention: CTM (Connective Tissue Massage)
Number of subjects: 14
Study 3399521 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham ultrasound)
Number of subjects: 14
Study 31594067 — intervention group
Group type: EXPERIMENTAL
Intervention: Night-time non-invasive ventilation (Bi-level positive airway pressure S/T, pressure set at 8-14 cmH(2)O inspiratory and 4-6 cmH(2)O expiratory)
Number of subjects: 17
Study 31594067 — intervention group
Group type: EXPERIMENTAL
Intervention: Night-time non-invasive ventilation
Number of subjects: 17
Study 31594067 — intervention group
Group type: COMPARATOR
Intervention: Control group (without ventilator)
Number of subjects: 17
Study 29693869 — intervention group
Group type: EXPERIMENTAL
Intervention: AV2 (two applications within four days)
Number of subjects: 50
Study 29693869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 25209014 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient rehabilitation after total hip and knee replacement
Number of subjects: 721
Study 24035351 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 73
Study 24035351 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 73
Study 21504883 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 25
Study 21504883 — intervention group
Group type: COMPARATOR
Intervention: Contact Control (CC)
Number of subjects: 25
Study 19225403 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐mg/kg propofol
Number of subjects: 14
Study 19225403 — intervention group
Group type: COMPARATOR
Intervention: 0.2‐mg/kg etomidate
Number of subjects: 14
Study 16782098 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox‐2 inhibitor treatment
Number of subjects: 56
Study 16782098 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment mentioned)
Number of subjects: 56
Study 15210550 — intervention group
Group type: EXPERIMENTAL
Intervention: OM6 scores in children with ear complaints
Number of subjects: 179
Study 15210550 — intervention group
Group type: EXPERIMENTAL
Intervention: OM6 scores in children with otitis media with effusion
Number of subjects: 179
Study 15210550 — intervention group
Group type: EXPERIMENTAL
Intervention: OM6 scores correlation with global quality-of-life measures
Number of subjects: 179
Study 15210550 — intervention group
Group type: EXPERIMENTAL
Intervention: OM6 scores in recurrent acute otitis media group
Number of subjects: 179
Study 15210550 — intervention group
Group type: EXPERIMENTAL
Intervention: OM6 scores in relation to demographic variables
Number of subjects: 179
Study 11156863 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/d 17ss‐estradiol continuously plus 0.025 mg gestodene for 12 days every month (standard‐progestin group)
Number of subjects: 321
Study 11156863 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg 17ss‐estradiol plus 0.025 mg gestodene for 12 days every third month (low‐progestin group)
Number of subjects: 321
Study 11156863 — intervention group
Group type: COMPARATOR
Intervention: No HRT (control group)
Number of subjects: 321
Study 11156863 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT (all groups)
Number of subjects: 321
Study 9225834 — intervention group
Group type: COMPARATOR
Intervention: Dextrose 5% 600 to 800 kcal.d‐1 (DX)
Number of subjects: 12
Study 9225834 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose 5% 600 to 800 kcal.d‐1 plus recombinant human growth hormone (DX + rGH)
Number of subjects: 12
Study 7906474 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% betaxolol
Number of subjects: 30
Study 7906474 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% timolol
Number of subjects: 30
Study 2444514 — intervention group
Group type: EXPERIMENTAL
Intervention: Latamoxef
Number of subjects: 30
Study 2444514 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime
Number of subjects: 30
Study 29760284 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 1209
Study 29760284 — intervention group
Group type: COMPARATOR
Intervention: Zotarolimus-eluting stent (ZES)
Number of subjects: 1209
Study 29760284 — intervention group
Group type: COMPARATOR
Intervention: Biodegradable polymer, biolimus-eluting stent (BP-BES)
Number of subjects: 1209
Study 29760284 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comparison of stents
Number of subjects: 1209
Study 25736389 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratitude intervention
Number of subjects: 119
Study 25736389 — intervention group
Group type: COMPARATOR
Intervention: Everyday events reporting (active control)
Number of subjects: 119
Study 25736389 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 119
Study 24073815 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive narrative intervention (4 weekly 60-min sessions)
Number of subjects: 82
Study 24073815 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 82
Study 22784975 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine/benazepril
Number of subjects: 169
Study 20354500 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection in the blood cardioplegic solution
Number of subjects: 75
Study 20354500 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mmol/L of L-arginine in the blood cardioplegic solution
Number of subjects: 75
Study 20354500 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mmol/L of L-arginine in the blood cardioplegic solution
Number of subjects: 75
Study 18584540 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole and Metronidazole (A/M) for 7 days
Number of subjects: 25
Study 18584540 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline and Folic Acid (T/F) for 28 days
Number of subjects: 25
Study 18584540 — intervention group
Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 25
Study 16203878 — intervention group
Group type: EXPERIMENTAL
Intervention: Early internal fixation with a Herbert screw without a cast (44 patients)
Number of subjects: 88
Study 16203878 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment with immobilization in a below-the-elbow plaster cast (44 patients)
Number of subjects: 88
Study 12000495 — intervention group
Group type: EXPERIMENTAL
Intervention: BUD (budesonide) 800 microg/day for 2 months, then 400 microg/day
Number of subjects: 75
Study 12000495 — intervention group
Group type: EXPERIMENTAL
Intervention: FP (fluticasone propionate) 500 microg/day for 2 months, then 200 microg/day
Number of subjects: 75
Study 12000495 — intervention group
Group type: COMPARATOR
Intervention: CROM (cromones)
Number of subjects: 75
Study 12000495 — intervention group
Group type: EXPERIMENTAL
Intervention: BUD (budesonide)
Number of subjects: 75
Study 12000495 — intervention group
Group type: EXPERIMENTAL
Intervention: FP (fluticasone propionate)
Number of subjects: 75
Study 10087407 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg progesterone b.i.d. by the vaginal route (Esolut, Angelini) starting on the day of oocyte pick up (Group A, n = 15)
Number of subjects: 30
Study 10087407 — intervention group
Group type: COMPARATOR
Intervention: 100 mg intramuscular progesterone once daily (Prontogest, Amsa) (Group B, n = 15)
Number of subjects: 30
Study 7608310 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg of moexipril
Number of subjects: 51
Study 7608310 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg of moexipril
Number of subjects: 51
Study 7608310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 2092880 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 352
Study 2092880 — intervention group
Group type: COMPARATOR
Intervention: Non-smokers
Number of subjects: 352
Study 340319 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 14
Study 340319 — intervention group
Group type: COMPARATOR
Intervention: Caloric supplementation
Number of subjects: 14
Study 31415448 — intervention group
Group type: EXPERIMENTAL
Intervention: APP (smartphone application)
Number of subjects: 38
Study 31415448 — intervention group
Group type: COMPARATOR
Intervention: No-APP (hard copy training program)
Number of subjects: 38
Study 31415448 — intervention group
Group type: EXPERIMENTAL
Intervention: APP
Number of subjects: 38
Study 31415448 — intervention group
Group type: COMPARATOR
Intervention: No-APP
Number of subjects: 38
Study 31204683 — intervention group
Group type: EXPERIMENTAL
Intervention: Visualization of asymptomatic atherosclerotic disease
Number of subjects: 3532
Study 31204683 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 3532
Study 27109625 — intervention group
Group type: EXPERIMENTAL
Intervention: Foster care intervention (N=40)
Number of subjects: 127
Study 27109625 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (N=40)
Number of subjects: 127
Study 27109625 — intervention group
Group type: COMPARATOR
Intervention: Never-institutionalized comparison group (N=47)
Number of subjects: 127
Study 27840443 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused shockwave therapy (FSWT; 2000 impulses, 4 Hz, 0.4 mJ/mm2)
Number of subjects: 43
Study 27840443 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial shockwave therapy (RSWT; 2000 impulses, 8 Hz, 5 bars + 2000 impulses, 8 Hz, 2.5 bars)
Number of subjects: 43
Study 27840443 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused shockwave therapy (FSWT)
Number of subjects: 43
Study 27840443 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial shockwave therapy (RSWT)
Number of subjects: 43
Study 25402398 — intervention group
Group type: EXPERIMENTAL
Intervention: iDecide (interactive, Web-based, tablet computer-delivered tool)
Number of subjects: 188
Study 25402398 — intervention group
Group type: COMPARATOR
Intervention: Print educational materials
Number of subjects: 188
Study 23146640 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow IANB with 3.6 mL of 2% lidocaine with 1:200,000 epinephrine
Number of subjects: 59
Study 23146640 — intervention group
Group type: COMPARATOR
Intervention: Rapid IANB with 3.6 mL of 2% lidocaine with 1:200,000 epinephrine
Number of subjects: 59
Study 20725124 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (30 min aerobic + 30 min resistance training)
Number of subjects: 38
Study 20725124 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (60 min treadmill walking)
Number of subjects: 38
Study 20725124 — intervention group
Group type: COMPARATOR
Intervention: Control group (no activity)
Number of subjects: 38
Study 18375320 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (7%) (1.2 mL/kg)
Number of subjects: 22
Study 18375320 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.9%) (1.2 mL/kg)
Number of subjects: 22
Study 15750756 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha-2a plus ribavirin 1,000/1,200 mg
Number of subjects: 27
Study 15750756 — intervention group
Group type: COMPARATOR
Intervention: Interferon alpha-2a plus ribavirin 600 mg
Number of subjects: 27
Study 12519136 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane with 70% N2O (group A)
Number of subjects: 114
Study 12519136 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane alone (group B)
Number of subjects: 114
Study 10897707 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced postgraduate education module for nurses in continence care
Number of subjects: 0
Study 8719151 — intervention group
Group type: EXPERIMENTAL
Intervention: Letters from physicians
Number of subjects: 0
Study 8719151 — intervention group
Group type: COMPARATOR
Intervention: Educational pamphlet
Number of subjects: 0
Study 8719151 — intervention group
Group type: COMPARATOR
Intervention: Letters inviting attendance at a women's health clinic
Number of subjects: 0
Study 8719151 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 1533432 — intervention group
Group type: EXPERIMENTAL
Intervention: S+TV+H
Number of subjects: 1
Study 1533432 — intervention group
Group type: EXPERIMENTAL
Intervention: S+TA+H
Number of subjects: 1
Study 1533432 — intervention group
Group type: EXPERIMENTAL
Intervention: S+TV
Number of subjects: 1
Study 1533432 — intervention group
Group type: EXPERIMENTAL
Intervention: H+TV
Number of subjects: 1
Study 1533432 — intervention group
Group type: EXPERIMENTAL
Intervention: H+TA
Number of subjects: 1
Study 1533432 — intervention group
Group type: EXPERIMENTAL
Intervention: S+H
Number of subjects: 1
Study 3933617 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven day course of amoxycillin 125 mg three times a day
Number of subjects: 274
Study 3933617 — intervention group
Group type: COMPARATOR
Intervention: Two day course of amoxycillin 750 mg twice a day
Number of subjects: 274
Study 31192975 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigecycline 1.2 mg/kg every 12 hours for children 8-11 years and 50 mg every 12 hours for children 12 to <18 years
Number of subjects: 0
Study 31192975 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigecycline
Number of subjects: 0
Study 28573765 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide (1.5 mg)
Number of subjects: 9901
Study 28573765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9901
Study 27460482 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline drinking to cope with negative affect
Number of subjects: 254
Study 27460482 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline drinking due to social pressure
Number of subjects: 254
Study 24239167 — intervention group
Group type: EXPERIMENTAL
Intervention: Xbox Kinect (XbK) training
Number of subjects: 63
Study 24239167 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional physiotherapy (TP) training
Number of subjects: 63